fasudil has been researched along with benzyloxycarbonylleucyl-leucyl-leucine aldehyde in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Hashimoto, K; Kawagoe, J; Kurachi, H; Morishige, K; Ohta, T; Takahashi, K; Takahashi, T; Takata, K; Tsutsumi, S; Yin, L | 1 |
2 other study(ies) available for fasudil and benzyloxycarbonylleucyl-leucyl-leucine aldehyde
Article | Year |
---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Fasudil-induced hypoxia-inducible factor-1alpha degradation disrupts a hypoxia-driven vascular endothelial growth factor autocrine mechanism in endothelial cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amides; Autocrine Communication; Cell Hypoxia; Cell Movement; Cell Nucleus; Drug Screening Assays, Antitumor; Endothelial Cells; Enzyme Activation; Gene Expression Regulation; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Leupeptins; Myosin Light Chains; Neovascularization, Pathologic; Phosphorylation; Protein Processing, Post-Translational; Protein Transport; Pyridines; rho-Associated Kinases; Ubiquitination; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2008 |